The Makers of the Omnipod® System

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, USA, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives.

Starting July 2018, Insulet began direct distribution of its Omnipod® Insulin Management System in Europe, including sales, marketing, training and customer support activities. This allowed Insulet to be closer to the diabetes community and to identify opportunities to support European customer needs over the long term, as it already does in the United States and Canada.

The Makers of the Omnipod® System

Ranked #4 on Forbes 2017 List of Most Innovative Growth Companies

Investors

Learn more about Insulet Corporation, an innovative medical device company based outside of Boston, MA, U.S.A.

 Visit our investor site

Careers

Our team is committed to making a difference in the lives of people with diabetes.

Search our openings

Delivery Systems

Partner with Insulet Delivery Systems Group to deliver the full potential of your drug via the Pod.

Learn more

Media and Investor Inquiries

We would be happy to talk to you further. Please contact us via mail, phone, or email:

Insulet Corporation
600 Technology Park Drive, Suite 200
Billerica, MA 01821

US Corporate telephone: 001 978 600 7850
US Corporate fax: 001 978 600 0120

European Headquarters telephone: 0800 011 6132 (number when calling from outside the UK +44 20 3887 1709)

Investor inquiries email: ir@insulet.com
Media inquiries email: pr@insulet.com